It seems that Sandy Alderson was asked by reporters yesterday if signing catcher Ronny Paulino was an “ethical and public relations” problem in light of Paulino’s suspension for taking a banned stimulant last year. Not surprisingly, Alderson said no, it was not.
People can ask what they want to ask of course, but I don’t recall this being an issue with other players who have been linked to PEDs. It is in keeping, however, with the curious scrutiny that some have given Alderson when it comes to PEDs and which is not given to other GMs who ran teams during the height of the steroid era. As if Alderson cooked up ‘roids in an old Winnebago in the desert with Jose Canseco or something. Which would be totally cool, of course, but it didn’t happen that way.
My view: there are rules in place governing PEDs now. The suspensions are part of those rules, as is the reinstatement of suspended players. Paulino did his time. There are no “ethical considerations” involved unless one does not respect the current rules in place. And if that’s the case, the questions are not for Sandy Alderson. They’re for Bud Selig.
Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.
It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.
Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.
A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.